Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Looking for participantsNCT06393816What this trial is testingFIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumWho this might be right forLarge Cell Neuroendocrine Carcinoma of the Lung Centre Leon Berard 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081What this trial is testingSelpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET ActivationWho this might be right forSolid TumorMedullary Thyroid Cancer Eli Lilly and Company 77
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272What this trial is testingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more 23andMe, Inc. 141
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06764368What this trial is testingPhase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Beijing Chest Hospital 39
Testing effectiveness (Phase 2)Study completedNCT01134250What this trial is testingCombination Therapy of F16IL2 and Paclitaxel in Solid Tumour PatientsWho this might be right forSolid TumorBreast CancerMetastatic Melanoma+1 more Philogen S.p.A. 48
Very early researchUnknownNCT02823691What this trial is testingThe MetNET-2 TrialWho this might be right forNeuroendocrine Tumors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 20
Testing effectiveness (Phase 2)Study completedNCT02697591What this trial is testingINCAGN01876 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced MalignanciesMetastatic Cancer Incyte Biosciences International Sàrl 100
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT05709821What this trial is testingIMM60 and Pembrolizumab in Melanoma and NSCLCWho this might be right forNon-small Cell Lung CancerMelanoma iOx Therapeutics 1
Testing effectiveness (Phase 2)Study completedNCT03548467What this trial is testingEvaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic CancerWho this might be right forLocally Advanced or Metastatic Solid Tumours Nykode Therapeutics ASA 41